British Journal of Cancer · 1999 · 138 citations · 36 references
MedicineGeneticsOncologyCancer GeneticsMolecular OncologyNeoplasiaBladder CancerProstate CancerAllele RetentionAllelic Imbalance DetectionDuplex Polymerase Chain ReactionHomozygous DeletionPten InactivationQuantitative Polymerase Chain Reaction AssaysSingle-strand Conformation PolymorphismTumor Suppressor Gene Mutations
The tumour suppressor gene PTEN/MMAC1, which is mutated or homozygously deleted in glioma, breast and prostate cancer, is mapped to a region of 10q which shows loss of heterozygosity (LOH) in bladder cancer. We screened 123 bladder tumours for LOH in the region of PTEN. In 53 informative muscle invasive tumours (> or = pT2), allele loss was detected in 13 (24.5%) and allelic imbalance in four tumours (overall frequency 32%). LOH was found in four of 60 (6.6%) informative, non-invasive tumours (pTa/pT1). We screened 63 muscle invasive tumours for PTEN mutations by single-strand conformation polymorphism (SSCP) analysis and for homozygous deletion by duplex quantitative polymerase chain reaction (PCR). Two homozygous deletions were identified but no mutations. Of 15 bladder tumour cell lines analysed, three showed homozygous deletion of all or part of the PTEN gene, but none had mutations detectable by SSCP analysis. Our results indicate that PTEN is involved in the development of some bladder tumours. The low frequency of mutation of the retained allele in tumours with 10q23 LOH suggests that there may be another predominant mechanism of inactivation of the second allele, for example small intragenic deletions, that hemizygosity may be sufficient for phenotypic effect, or that there is another target gene at 10q23.
36
Jing Li, Clifford Yen, Danny Liaw et al. · Science · 1997 · 4.8K citations
Comparative Genomic Hybridization for Molecular Cytogenetic Analysis of Solid Tumors
Anne Kallioniemi, Olli Kallioniemi, Damir Sudar et al. · Science · 1992 · 3.3K citations
Frequent inactivation of PTEN/MMAC1 in primary prostate cancer.
P Cairns, Kenji Okami, Sarel Halachmi et al. · PubMed · 1997 · 711 citations
Life Sciences, Genetics, Oncology +16